Feld L G, Stapleton F B, Duffy L
Department of Pediatrics, Children's Hospital of Buffalo, New York 14222.
Pediatr Nephrol. 1993 Aug;7(4):441-3. doi: 10.1007/BF00857563.
The decision to perform a renal biopsy on children with asymptomatic hematuria or proteinuria remains a problem for clinicians. To assess the current opinion of 349 pediatric nephrologists on this issue, case summaries of a 9-year-old boy with 20 urinary red blood cells per high power field without proteinuria and a 9-year-old boy with 2+ proteinuria (600 mg/day) without hematuria were distributed to each specialist. Seventy-three percent (n = 256; 3:1, male:female) responded. Five percent would biopsy the child with asymptomatic hematuria. The main reasons were academic interest, parental pressure for a diagnosis/prognosis and concern for future economic impact on the child (i.e., life insurance). The determinations to biopsy for hematuria were not related to age or sex of the nephrologist. In contrast, 38% (n = 96) of the pediatric nephrologists would perform a biopsy on the child with proteinuria. The major reasons for biopsy were academic interest and potential for drug therapy. With a normal history, physical examination and laboratory/radiographic evaluation, the vast majority of pediatric nephrologists in North America support a conservative approach to the child with asymptomatic hematuria or proteinuria.
对于患有无症状血尿或蛋白尿的儿童,是否进行肾活检仍是临床医生面临的一个问题。为评估349名儿科肾病专家对该问题的当前看法,向每位专家分发了两名9岁男孩的病例摘要,一名男孩每高倍视野有20个尿红细胞但无蛋白尿,另一名男孩有2+蛋白尿(600毫克/天)但无血尿。73%(n = 256;男女比例为3:1)的专家做出了回应。5%的专家会对无症状血尿患儿进行活检。主要原因是学术兴趣、家长要求诊断/预后的压力以及对患儿未来经济影响(如人寿保险)的担忧。决定对血尿患儿进行活检与肾病专家的年龄或性别无关。相比之下,38%(n = 96)的儿科肾病专家会对蛋白尿患儿进行活检。活检的主要原因是学术兴趣和药物治疗的可能性。在病史、体格检查及实验室/影像学评估均正常的情况下,北美绝大多数儿科肾病专家支持对无症状血尿或蛋白尿患儿采取保守治疗方法。